GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,283.00p
   
  • Change Today:
      8.00p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,120.05m
  • Volume: 4,050,575
  • Market Cap: £52,860m
  • RiskGrade: 129
  • Beta: 0.06

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
3.42% below the market average3.42% below the market average3.42% below the market average3.42% below the market average3.42% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
1yr Revenue Growth
6.41% below the market average6.41% below the market average6.41% below the market average6.41% below the market average6.41% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
23.24% above the market average23.24% above the market average23.24% above the market average23.24% above the market average23.24% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
4.83% above the market average4.83% above the market average4.83% above the market average4.83% above the market average4.83% above the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
9.16% below the market average9.16% below the market average9.16% below the market average9.16% below the market average9.16% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Price Book Ratio
77.04% below the market average77.04% below the market average77.04% below the market average77.04% below the market average77.04% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
71.67% below the market average71.67% below the market average71.67% below the market average71.67% below the market average71.67% below the market average
45.83% below the sector average45.83% below the sector average45.83% below the sector average45.83% below the sector average45.83% below the sector average
Price Chg 3m
4.19% above the market average4.19% above the market average4.19% above the market average4.19% above the market average4.19% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
54.12% below the market average54.12% below the market average54.12% below the market average54.12% below the market average54.12% below the market average
68.89% below the sector average68.89% below the sector average68.89% below the sector average68.89% below the sector average68.89% below the sector average
Momentum 20
94.41% below the market average94.41% below the market average94.41% below the market average94.41% below the market average94.41% below the market average
91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
18.44% above the market average18.44% above the market average18.44% above the market average18.44% above the market average18.44% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
ROCE
72.09% above the market average72.09% above the market average72.09% above the market average72.09% above the market average72.09% above the market average
Sector averageSector averageSector averageSector averageSector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.56% above the market average91.56% above the market average91.56% above the market average91.56% above the market average91.56% above the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Forecast EPS
81.01% above the market average81.01% above the market average81.01% above the market average81.01% above the market average81.01% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.67% above the market average97.67% above the market average97.67% above the market average97.67% above the market average97.67% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
Operating Profit Loss
98.09% above the market average98.09% above the market average98.09% above the market average98.09% above the market average98.09% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average
95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average
Cash
96.83% above the market average96.83% above the market average96.83% above the market average96.83% above the market average96.83% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
72.96% above the market average72.96% above the market average72.96% above the market average72.96% above the market average72.96% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Buys 1y
99.34% above the market average99.34% above the market average99.34% above the market average99.34% above the market average99.34% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
92.06% below the market average92.06% below the market average92.06% below the market average92.06% below the market average92.06% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
Brokers Percent Neutral
76.22% above the market average76.22% above the market average76.22% above the market average76.22% above the market average76.22% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,283.00p
Change Today 8.00p
% Change 0.63 %
52 Week High 1,812.50p
52 Week Low 1,264.00p
Volume 4,050,575
Shares Issued 4,120.05m
Market Cap £52,860m
Beta 0.06
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.38% below the market average26.38% below the market average26.38% below the market average26.38% below the market average26.38% below the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Price Trend
30.76% below the market average30.76% below the market average30.76% below the market average30.76% below the market average30.76% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Income
75.24% above the market average75.24% above the market average75.24% above the market average75.24% above the market average75.24% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
46.11% below the market average46.11% below the market average46.11% below the market average46.11% below the market average46.11% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 11-Apr-2025

Time Volume / Share Price
13:58 0 @ 1,283.00p
13:58 367 @ 1,283.00p
13:58 839 @ 1,283.00p
13:58 254 @ 1,283.00p
13:58 728 @ 1,283.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page